Last updated on November 2017

A Phase 3, Placebo-Controlled, Randomized, Observer-Blinded Study to Evaluate The Efficacy, Safety, and Tolerability of A Clostridium Difficile Vaccine In Adults 50 Years Of Age and Older


Brief description of study

A Phase 3, Placebo-Controlled, Randomized, Observer-Blinded Study to Evaluate The Efficacy, Safety, and Tolerability of A Clostridium Difficile Vaccine In Adults 50 Years Of Age and Older

Detailed Study Description

We are conducting a study to find out if an investigational vaccine prevents severe diarrhea caused by a germ (bacterium) called Clostridium difficile (C diff) in subjects 50 year of age and older

.

Clinical Study Identifier: TX11887

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Kristin Quimby

Community Clinical Research Center
Anderson, IN USA
  Connect »

Lauren Sullivan

Clinical Research Atlanta
Stockbridge, GA USA
  Connect »